Advertisement

Neonatology pp 1607-1618 | Cite as

Congenital Immunodeficiencies in Newborns

  • Alessandro Plebani
  • Gaetano Chirico
  • Vassilios Lougaris
Reference work entry

Abstract

Congenital immunodeficiency diseases are a group of primarily single-gene disorders of the immune system. To date, more than 300 genetic defects have been identified as responsible for congenital immunodeficiencies. Although diverse, these diseases share the common features of susceptibility to infections and result in substantial morbility and shortened life spans. The severity of congenital immunodeficiencies largely depends on the arm of the immune system affected, and being congenital many of these disorders have their clinical symptoms early in infancy. In syndromic immunodeficiencies, the defects of the immune system may not represent the major clinical problem. Most important, prompt diagnosis and treatment can lead in marked improvement in the quality and length of life and better outcome. The possibility to apply the neonatal screening test for severe combined immunodeficiency will further ameliorate patients’ outcome.

References

  1. Azzari C, la Marca G, Resti M (2011) Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. J Allergy Clin Immunol 127(6):1394–1399CrossRefGoogle Scholar
  2. Boisson B, Wang YD, Bosompem A, Ma CS, Lim A, Kochetkov T, Tangye SG, Casanova JL, Conley ME (2013) A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR-B cells. J Clin Invest 123:4781–4785CrossRefGoogle Scholar
  3. Conley ME, Dobbs AK, Farmer DM et al (2009) Primary B cell immunodeficiencies: comparisons and contrasts. Ann Rev Immunol 27:199–227CrossRefGoogle Scholar
  4. Deau MC, Heurtier L, Frange P et al (2014) A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest 124(9):3923–3928CrossRefGoogle Scholar
  5. Durandy A, Revy P, Fischer A (2007) Autosoma hyper-IgM syndromes caused by an intrinsic B cell defect. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiencies diseases. A molecular and genetic approach. Oxford University Press, New York, pp 269–278Google Scholar
  6. Fischer A, Notarangelo LD (2004) Combined immunodeficiencies. In: Stiehm ER, Ochs HD, Winkelstein JA (eds) Immunologic disorders in infants and children. Elsevier, Philadelphia, pp 447–479Google Scholar
  7. Geha RS, Plebani A, Notarangelo LD (2007) CD40, CD40 ligand, and the hyper IgM syndrome. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiencies diseases. A molecular and genetic approach. Oxford University Press, New York, pp 251–268Google Scholar
  8. Goldmuntz E (2005) DiGeorge sindrome: new insights. Clin Perinatol 32:963–978CrossRefGoogle Scholar
  9. Hermanns P, Tran A, Munivez E et al (2006) RMRP mutations in cartilage hair hypoplasia. Am J Med Genet 140:2121–2130CrossRefGoogle Scholar
  10. Kwan A, Abraham RS, Currier R et al (2014) Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312(7):729–738Google Scholar
  11. Lougaris V, Tampella G, Baronio M et al (2014) The genetic heterogeneity of Common Variable Immunodeficiency (CVID): an update. J Vaccines Vaccin 5:223.  https://doi.org/10.4172/2157-7560.1000223CrossRefGoogle Scholar
  12. Mohiuddin MS, Abbott JK, Hubbard N et al (2013) Diagnosis and evaluation of primary panhypogammaglobulinemia: a molecular and genetic challenge. J Allergy Clin Immunol 131(6):1717–1718CrossRefGoogle Scholar
  13. Moraes-Vasconcelos D, Costa-Carvalho BT, Torgerson TR et al (2008) Primary immune deficiency disorders presenting as autoimmune diseases IPEX and APECED. J Clin Immunol 28:S11–S19CrossRefGoogle Scholar
  14. Ochs HD, Thrasher AJ (2006) The Wiskott-Aldrich sindrome. J Allergy Clin Immunol 117:725–738CrossRefGoogle Scholar
  15. Park MA, Li JT, Hagan JB et al (2009) Common variable immunodeficiency: a new look at an old disease. Lancet 372:489–502CrossRefGoogle Scholar
  16. Rieth W, Lisowska-Grospierre B, Fischer A (2007) Molecular basis of major histocompatibility complex class II deficiency. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiencies diseases. A molecular and genetic approach. Oxford University Press, New York, pp 227–241Google Scholar
  17. The International Nijmegen Breakage Syndrome Study Group (2000) Nijmegen breakage sindrome. Arch Dis Child 82:400–406CrossRefGoogle Scholar
  18. Worth AJ, Thrasher AJ (2015) Current and emerging treatment options for Wiscott-Aldrich syndrome. Expert Rev Clin Immunol 11(9):1015–1032CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Alessandro Plebani
    • 1
  • Gaetano Chirico
    • 2
  • Vassilios Lougaris
    • 1
  1. 1.Pediatrics Clinic, Department of Clinical and Experimental SciencesUniversity of Brescia and Spedali Civili of BresciaBresciaItaly
  2. 2.Neonatology and Intensive Neonatal Therapy UnitSpedali Civili of BresciaBresciaItaly

Personalised recommendations